Alabama's Cannabis Industry Faces Uncertainty As Controversy And Lawsuits Rock Its Licensing Program

Zinger Key Points
  • While the AMCC is reevaluating business license applications, companies denied licenses are filing lawsuits.
  • Oscity Labs is the most recent company to go to court over the beleaguered medical marijuana licensing program.

It seems Alabama's Medical Cannabis Commission (AMCC) is heading back to the drawing board in the midst of controversy and legal battles over its licensing program.

AMCC members recently announced that they'll seek an independent review of all scoring data following suspicions of possible irregularities in assessing applicants. Though the regulatory body did not confirm whether it had any evidence suggesting that malpractice had occurred in the process.

However, in late June the commission suspended all licensing for cultivators, dispensaries and related businesses involved in the state's fledgling medical marijuana (MMJ) program. That move came on the heels of having awarded the first 21 licenses for medical cannabis production, testing, transportation and distribution under the 2021 legalization law. More than 90 operators have applied for licenses.

While the AMCC is reevaluating business license applications, companies that were denied are filing lawsuits in an effort to secure their fair chance to get into the state's MMJ market.

The Latest Lawsuit

A South Alabama-based hemp cultivator and processor, Oscity Labs is the latest company to take its greviances to court where it is challenging "potential inconsistencies" in scoring, reported WPMI.

The University of South Alabama oversees the process of supervising the scoring process, as per an earlier update.

According to Oscity's motion to intervene, which a Montgomery County Judge granted on Thursday, the company "received only 13% of available points for Quality Control and Testing although its facility has a state-of-the-art laboratory and its processes and products have been certified to meet all requirements of both by the Alabama Department of Agriculture and FDA."

Oscity, co-founded by former Mobile Mayor Mike Dow, already manufactures CBD products.

"Let us explain to you that we're already manufacturing," said Oscity's CEO Ray French. "We're a cGMP-certified facility. We have these federal certifications that take a year to accomplish. So you can't just build a factory and then the next day be operational."

French added that the company's 350-acre farm in Escambia County nor the 100,000-square-foot facility in Foley has ever been visited by officals doing the scoring.

Other Companies Seeking Justice

Meanwhile, Redbud Remedies is among three other organizations involved in lawsuits against the commission. Redbud is claiming that file-size restrictions on the agency's online application portal caused their documents to be discarded.

The other two applicants, Med Shop Dispensary and Thera True Alabama had their applications considered by the commission following Montgomery Circuit Judge James Anderson ruling in April. Redbud Remedies did not.

In May, the company appealed to the Alabama Court of Civil Appeals. Recently, it requested an emergency stay in the selection of dispensary licenses. Redbud Remedies also filed a motion for an injunction pending an appeal filed in Montgomery County Circuit Court.

What's Next?

In an attempt to restart the selection process, the commission established a deadline of August 10th to void previously granted licenses.

Photo: Courtesy of Billion Photos and Yarygin by Shutterstock

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisGovernmentM&ANewsRegulationsPoliticsLegalMarketsGeneralAlabama CannabisAlabama Medical Cannabis CommissionMed Shop DispensaryMike DowOscity LabsRay FrenchRedBud RemediesThera True Alabama
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...